Evidence map›Paper›PMID 21300151›Full record

ReviewThe Journal of steroid biochemistry and molecular biology2011

Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways.

Cheryl S Watson, Yow-Jiun Jeng, Jutatip Guptarak

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of steroid biochemistry and molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Are BPA Substitutes as Obesogenic as BPA?International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Estrogens regulate life and death in mitochondria.Journal of bioenergetics and biomembranes · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cheryl S WatsonDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0645, USA. cswatson@utmb.edu
Yow-Jiun Jeng
Jutatip Guptarak
The University of Texas Medical Branch at Galveston · US

Funding

Molecular Mechanisms of Environmental InjuryT32ES007254 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI AMEREDES, BILL T · 1990 to 2022
$6.6M
Nongenomic Signaling Mechanisms of Environmental EstrogensR01ES015292 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WATSON, CHERYL S · 2007 to 2011
$1.2M
Environmental Estrogens Acting via a Membrane ReceptorR01ES010987 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WATSON, CHERYL S · 2002 to 2004
$660k
NIEHS NIH HHS ES015292NIEHS NIH HHS R01 ES010987NIEHS NIH HHS R01 ES015292NIEHS NIH HHS T32 ES007254NIEHS NIH HHS T32-ES07254
6 · The paper itself

Abstract

When inappropriate (non-physiologic) estrogens affect organisms at critical times of estrogen sensitivity, disruption of normal endocrine functions can result. Non-physiologic estrogen mimetics (environmental, dietary, and pharmaceutical) can signal rapidly and potently via the membrane versions of estrogen receptors, as can physiologic estrogens. Both physiologic and non-physiologic estrogens activate multiple signaling pathways, leading to altered cellular functions (e.g. peptide release, cell proliferation or death, transport). Xenoestrogens' mimicry of physiologic estrogens is imperfect. When superimposed, xenoestrogens can alter endogenous estrogens' signaling and thereby disrupt normal signaling pathways, leading to malfunctions in many tissue types. Though these xenoestrogen actions occur rapidly via nongenomic signaling pathways, they can be sustained with continuing ligand stimulation, combinations of ligands, and signaling that perpetuates downstream, eventually also impinging on genomic regulation by controlling the activation state of transcription factors. Because via these pathways estrogens and xenoestrogens cause nonmonotonic stimulation patterns, they must be carefully tested for activity and toxicity over wide dose ranges. Nongenomic actions of xenoestrogens in combination with each other, and with physiologic estrogens, are still largely unexplored from these mechanistic perspectives.

Indexed as

AnimalsApoptosisCell ProliferationEndocrine DisruptorsEstrogensFemaleHumansMaleMiceRatsReceptors, EstrogenSignal TransductionEndocrine DisruptorsEstrogensReceptors, Estrogen

Identifiers

PMID21300151
PMCPMC3106143
OpenAlexW2006252312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.